跳至主要内容
临床试验/NCT01179373
NCT01179373已完成2 期

Phase 2 Study of Trans Cranial Magnetic Stimulation as Additional Therapy Patients With Alzheimer's Disease

Brainsway1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2010年8月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
Brainsway
入组人数
45
试验地点
1
主要终点
cognitive functioning score by ADAS-COG

研究概览

简要总结

The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H coil to prefrontal cortex , with an addition of cognitive brain training, to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.

详细描述

Primary outcome measure: ADAS-COG (time frame baseline, 2 months, 4 months) Secondary outcome measure: CGI-C,FAB, ADL, Neuropsychological computerized test(time frame baseline, 2 months, 4 months.

Estimated enrollment: 40 patients Estimated Study start Date: November 2008 Estimated Study Completion date: November 2009 Number of arms: 2

Ages: 50-85 Genders: both

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged 50-
  • Diagnosed with Alzheimer's disease for at least one year (by the DSM-IV criteria).
  • Scored below 24 on the MMSE.
  • Received drug therapy for their disease, with each treatment having been administered at an acceptable dosage for at least 5 weeks, with either no effect or only partial response.
  • Answered in the negative to all questions in the pre-TMS treatment safety questionnaire.
  • Gave their oral and written consent to participate in the trial.

排除标准

  • An additional neurological or psychiatric disorder.
  • Severe personality disorder.
  • Uncontrolled hypertension.
  • History of epilepsy, seizure, or heat convulsion.
  • History of epilepsy or seizure in first degree relatives.
  • History of head injury or stroke.
  • History of metal implants in the head (except dental fillings).
  • History of surgery entailing metallic implants or known history of any metallic particles in the eye, implanted cardiac pacemaker, cochlear implants, use of neurostimulators, or any medical pumps.
  • History of migraines in the last six months.
  • History of drug or alcohol abuse.
  • Inadequate communication with examiner.
  • Participation in another clinical study, either concurrent with this trial or in the 3 months preceding it.
  • Inability to sign a consent form.

研究组 & 干预措施

TMS, High Frequency

Active Comparator

High Frequency TMS with H coil to prefrontal cortex

干预措施: TMS, H coil (Device)

TMS, Low Frequency

Active Comparator

Low Frequency TMS to Prefrontal cortex

干预措施: TMS, H coil (Device)

Sham Stimulation

Placebo Comparator

Sham TMS with H Coil on Prefrontal Cortex

干预措施: TMS, H coil (Device)

结局指标

主要结局

cognitive functioning score by ADAS-COG

时间窗: 4 months

次要结局

  • Global advancement score by CGI-C(4 months)
  • Frontal lobe functioning score by FAB(4 months)
  • Daily activity score by ADL(4 months)

研究者

发起方
Brainsway
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验